Unlike most other carcinomas arising from the follicular cell of the thyroid, medullary thyroid carcinoma (MTC) is a malignancy with neuroendocrine features, derived from the parafollicular C cell, which is of ectodermal neural crest origin. In most studies, MTC represents 3–12% of thyroid cancers, the majority of which are sporadic. However, in approximately 25–30% of cases, MTC is inherited, and is associated with one of three familial syndromes: multiple endocrine neoplasia (MEN) syndrome type 2A, MEN type 2B, and familial MTC (Table 10.1). In contrast to sporadic cases of MTC, germline RET proto-oncogene mutations are often detected in inherited cases, which may facilitate early diagnosis.
Crest Calcitonin Goiter Rounded Congo
This is a preview of subscription content, log in to check access
Borrello MG. RET activation by germline MEN-2A and MEN-2B mutations. Oncogene 1995;11:2419.PubMedGoogle Scholar
Dennis Frisman. Immunoquery: Immunohistochemistry literature database program. n.d. http://www.immunoquery.com (January 15, 2004).
Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET protooncogene are associated with MEN2A and FMTC. Hum Mol Genet 1993;2:851–856.PubMedCrossRefGoogle Scholar
Duh QY, Sancho JJ, Greenspan FS, et al. Medullary thyroid carcinoma: the need for early diagnosis and total thyroidectomy. Arch Surg 1989;124:1206–1210.PubMedCrossRefGoogle Scholar
Forrest CH, et al. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer (Phila) 1998;84:295.CrossRefGoogle Scholar
Kaserer K, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 1998;22:722.PubMedCrossRefGoogle Scholar
Mulligan LM, et al. Genetic events in tumor initiation and progression in MEN type 2. Genes Chromosomes Cancer 1993;6:166.PubMedCrossRefGoogle Scholar
Randolph GW, De la Cruz A, Faquin WC. Medullary carcinoma of the thyroid. In: Pellitteri PK, McCaffrey TV (eds) Endocrine surgery of the head and neck. Clifton Park, NY: Thomson Delmar Learning, 2003:167–182.Google Scholar
Vierhopper H, et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997;82:1589.CrossRefGoogle Scholar